Literature DB >> 19453252

Chronic pancreatitis: genetics and pathogenesis.

Jian-Min Chen1, Claude Férec.   

Abstract

Chronic pancreatitis (CP) is a persistent inflammation of the pancreas. Over the past 12 years, genetic studies of hereditary, familial, and idiopathic forms of CP have made great progress in defining the disease pathogenesis. Identification of gain-of-function missense and copy number mutations in the cationic trypsinogen gene (PRSS1) and loss-of-function variants in both the pancreatic secretory trypsin inhibitor (SPINK1) and chymotrypsinogen C (CTRC) genes has firmly established the pivotal role of prematurely activated trypsin within the pancreas in the etiology of CP. Loss-of-function variants in the cystic fibrosis transmembrane conductance regulator (CFTR) and calcium-sensing receptor (CASR) genes also increase the risk of CP. Here, we review recent developments in this rapidly evolving field, highlight the importance of gene-gene and gene-environment interactions in causing the disease, and discuss the opportunities and challenges in identifying novel genetic factors that affect susceptibility/resistance to CP.

Entities:  

Mesh:

Year:  2009        PMID: 19453252     DOI: 10.1146/annurev-genom-082908-150009

Source DB:  PubMed          Journal:  Annu Rev Genomics Hum Genet        ISSN: 1527-8204            Impact factor:   8.929


  54 in total

Review 1.  Chymotrypsin C mutations in chronic pancreatitis.

Authors:  Jiayi Zhou; Miklós Sahin-Tóth
Journal:  J Gastroenterol Hepatol       Date:  2011-08       Impact factor: 4.029

2.  Strong purifying selection against gene conversions in the trypsin genes of primates.

Authors:  Nicholas Petronella; Guy Drouin
Journal:  Hum Genet       Date:  2012-06-30       Impact factor: 4.132

Review 3.  Specialized roles for cysteine cathepsins in health and disease.

Authors:  Jochen Reiser; Brian Adair; Thomas Reinheckel
Journal:  J Clin Invest       Date:  2010-10-01       Impact factor: 14.808

Review 4.  Genetics of pancreatitis: an update for clinicians and genetic counselors.

Authors:  Sheila Solomon; David C Whitcomb
Journal:  Curr Gastroenterol Rep       Date:  2012-04

Review 5.  What is personalized medicine and what should it replace?

Authors:  David C Whitcomb
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-05-22       Impact factor: 46.802

Review 6.  Genetic risk factors for pancreatic disorders.

Authors:  David C Whitcomb
Journal:  Gastroenterology       Date:  2013-06       Impact factor: 22.682

7.  Trypsinogen activation in acute and chronic pancreatitis: is it a prerequisite?

Authors:  Raghuwansh P Sah; Ashok K Saluja
Journal:  Gut       Date:  2011-06-14       Impact factor: 23.059

8.  Genetics and treatment options for recurrent acute and chronic pancreatitis.

Authors:  Celeste A Shelton; David C Whitcomb
Journal:  Curr Treat Options Gastroenterol       Date:  2014-09

9.  Targeted next-generation sequencing effectively analyzed the cystic fibrosis transmembrane conductance regulator gene in pancreatitis.

Authors:  Eriko Nakano; Atsushi Masamune; Tetsuya Niihori; Kiyoshi Kume; Shin Hamada; Yoko Aoki; Yoichi Matsubara; Tooru Shimosegawa
Journal:  Dig Dis Sci       Date:  2014-12-10       Impact factor: 3.199

10.  Complete ascertainment of intragenic copy number mutations (CNMs) in the CFTR gene and its implications for CNM formation at other autosomal loci.

Authors:  Sylvia Quemener; Jian-Min Chen; Nadia Chuzhanova; Caroline Bénech; Teresa Casals; Milan Macek; Thierry Bienvenu; Trudi McDevitt; Philip M Farrell; Ourida Loumi; Taieb Messaoud; Harry Cuppens; Garry R Cutting; Peter D Stenson; Karine Giteau; Marie-Pierre Audrézet; David N Cooper; Claude Férec
Journal:  Hum Mutat       Date:  2010-04       Impact factor: 4.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.